At early stages, tumor IL-33 levels were lower than its corresponding non-tumor distant tissue (p = 0.02 and 0.03 for TNM stage 1 and 2), however, stage 3 tumor tissue show increased IL-33 compared to stage 1 (p = 0.03, Figure 1F). This evidence concerns the gene IL33 and neoplasm.